A Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)
Clinical trial NCT02452372 · COMPLETED
Trial details
- NCT number
- NCT02452372
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-06
- Primary completion
- 2017-09-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.